Compare Progressive Corp (PGR) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Progressive Corp vs 22nd Century Group Inc — how do they compare? Progressive Corp trades at $217.43 (market cap $126.95B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Progressive Corp is far larger — about 204208× 22nd Century Group Inc's market cap, and Progressive Corp pays a 0.18% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Progressive Corp for 81 Days and 22nd Century Group Inc for 32 Days on average.
| PGR | XXII | |
|---|---|---|
Market Cap | $126.95B | $621.67K |
Volume | 2,749,438 | 45,625 |
Sector | Financials | Consumer Staples |
52-Week High | $242.16 | $483.00 |
52-Week Low | $190.40 | $0.80 |
Typical Hold Time | 81 Days | 32 Days |
Enterprise Value | $135.16B | -$3.69M |
Dividend Yield | 0.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Progressive Corporation (PGR) trades at $217.43, up 1.55% with a bullish technical outlook supported by moving averages and strong institutional interest. The company demonstrates robust fundamentals with revenue growing from $49.6B in 2022 to $87.6B in 2025, net income reaching $11.3B, and impressive profitability metrics including 34.94% ROE. Recent earnings show mixed results with Q2 2026 beating expectations while Q1 2026 missed, with Q3 2026 results pending.
The stock presents a compelling value opportunity with a P/E of 10.97 and positive analyst sentiment (38.1% buy ratings), though competitive pressures in auto insurance and potential market volatility pose risks. With a consensus price target of $222.23 offering modest upside, PGR remains well-positioned for long-term growth given its operational strength and dividend consistency.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Progressive Corp
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
